Company / Operating Cash Flow per Share
PUMA BIOTECHNOLOGY, INC. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.55
FY2025
5-year range
-$0.33 / $0.56
FY2021-FY2025
Trend
+265.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed +266% YoY in FY2025, a notable deviation from the 8-year average annual change of +317%.
Based on SEC 10-K filings.
0.55 in FY2025 with a 3-year CAGR of +208.3%.
Improved from $0.45 to $0.55 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +208.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 265.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2019.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.55 | +265.6% |
| FY2024 | -$0.33 | -174.6% |
| FY2023 | $0.45 | +2273.4% |
| FY2022 | $0.02 | -96.6% |
| FY2021 | $0.56 | +190.8% |
| FY2020 | -$0.61 | +86.3% |
| FY2019 | -$4.50 | -19.4% |
| FY2018 | -$3.77 | +10.1% |
| FY2017 | -$4.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026